Stéphane Bancel speaking at Endpoints @ #JPM20 (Photo: Jeff Rumans for Endpoints News)
January 31, 2022 01:51 PM ESTUpdated 02:12 PM
Bioregnum
Pharma
FDA+

The FDA ap­proves Mod­er­na's rev­o­lu­tion­ary new Covid-19 vac­cine. What took so long?

Mod­er­na just picked up its first-ever full BLA ap­proval for its cel­e­brat­ed Covid-19 vac­cine, and did it at what most every­one in the busi­ness would …

Endpoints Premium

This article is available only to Premium subscribers

Upgrade to Premium for unlimited access and Premium exclusives.

UPGRADE
TRENDING NOW

Trump asks 'very tough hom­bre' Dr. Oz to lead MFN talks

US warns drug­mak­ers against mis­rep­re­sent­ing cost of im­port­ed prod­ucts

End­points 100 biotech sur­vey: Wel­come to the sum­mer of biotech’s dis­con­tent

Meet the ‘first sale’ rule: A cus­toms loop­hole phar­ma com­pa­nies could use to ease tar­iff im­pact

About 5% of CBER and CDER left af­ter FDA staff cuts, analy­sis finds

sponsored

Does your sup­ply chain hold up un­der pres­sure for high-risk tem­per­a­ture-crit­i­cal ship­ments?

A service from the Financial Times